Literature DB >> 10496907

Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.

R C Langer1, M W Riggs.   

Abstract

Cryptosporidiosis, caused by the apicomplexan parasite Cryptosporidium parvum, has become a well-recognized diarrheal disease of humans and other mammals throughout the world. No approved parasite-specific drugs, vaccines, or immunotherapies for control of the disease are currently available, although passive immunization with C. parvum-specific antibodies has some efficacy in immunocompromised and neonatal hosts. We previously reported that CSL, an approximately 1,300-kDa conserved apical glycoprotein of C. parvum sporozoites and merozoites, is the antigenic species mechanistically bound by neutralizing monoclonal antibody 3E2 which elicits the circumsporozoite precipitate (CSP)-like reaction and passively protects against C. parvum infection in vivo. These findings indicated that CSL has a functional role in sporozoite infectivity. Here we report that CSL has properties consistent with being a sporozoite ligand for intestinal epithelial cells. For these studies, native CSL was isolated from whole sporozoites by isoelectric focusing (IEF) following observations that the approximately 1,300-kDa region containing CSL as seen by sodium dodecyl sulfate-polyacrylamide gel electrophoresis was comprised of approximately 15 molecular species (pI 3 to 10) when examined by two-dimensional (2-D) electrophoresis and silver staining. A subset of six approximately 1,300-kDa species (pI 4.0 to 6.5) was specifically recognized by 3E2 in 2-D Western immunoblots of IEF-isolated CSL. Isolated native CSL bound specifically and with high affinity to permissive human intestinal epithelial Caco-2 cells in a dose-dependent, saturable, and self-displaceable manner. Further, CSL specifically bound to the surface of live Caco-2 cells inhibited sporozoite attachment and invasion. In addition, sporozoites having released CSL after incubation with 3E2 and occurrence of the CSP-like reaction did not attach to and invade Caco-2 cells. These findings indicate that CSL contains a sporozoite ligand which facilitates attachment to and invasion of Caco-2 cells and, further, that ligand function may be disrupted by CSL-reactive monoclonal antibody. We conclude that CSL is a rational target for passive or active immunization against cryptosporidiosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496907      PMCID: PMC96882          DOI: 10.1128/IAI.67.10.5282-5291.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Sequence of the gene encoding an immunodominant microneme protein of Eimeria tenella.

Authors:  F M Tomley; L E Clarke; U Kawazoe; R Dijkema; J J Kok
Journal:  Mol Biochem Parasitol       Date:  1991-12       Impact factor: 1.759

2.  Characterization of a high molecular weight antigen of Cryptosporidium parvum micronemes possessing epitopes that are cross-reactive with all parasitic life cycle stages.

Authors:  B Robert; H Antoine; F Dreze; P Coppe; A Collard
Journal:  Vet Res       Date:  1994       Impact factor: 3.683

3.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

Authors:  M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1987-04       Impact factor: 1.276

4.  Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue culture cells.

Authors:  R Lumb; K Smith; P J O'Donoghue; J A Lanser
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

5.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes.

Authors:  L E Perryman; D P Jasmer; M W Riggs; S G Bohnet; T C McGuire; M J Arrowood
Journal:  Mol Biochem Parasitol       Date:  1996-10-01       Impact factor: 1.759

6.  Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies.

Authors:  M Tilley; M T Eggleston; S J Upton
Journal:  FEMS Microbiol Lett       Date:  1993-10-15       Impact factor: 2.742

7.  Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid.

Authors:  M W Riggs; M R McNeil; L E Perryman; A L Stone; M S Scherman; R M O'Connor
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Rhoptry organelles of the apicomplexa: Their role in host cell invasion and intracellular survival.

Authors:  T Y Sam-Yellowe
Journal:  Parasitol Today       Date:  1996-08

9.  Analysis of adhesion and cytotoxicity of Tritrichomonas foetus to mammalian cells by use of monoclonal antibodies.

Authors:  D E Burgess; C M McDonald
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells.

Authors:  A Joe; R Verdon; S Tzipori; G T Keusch; H D Ward
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more
  14 in total

1.  Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  DING proteins: numerous functions, elusive genes, a potential for health.

Authors:  François Bernier
Journal:  Cell Mol Life Sci       Date:  2013-06-07       Impact factor: 9.261

3.  Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15.

Authors:  A M Cevallos; X Zhang; M K Waldor; S Jaison; X Zhou; S Tzipori; M R Neutra; H D Ward
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Identification of novel Plasmodium gallinaceum zygote- and ookinete-expressed proteins as targets for blocking malaria transmission.

Authors:  Rebecca C Langer; Fengwu Li; Joseph M Vinetz
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 5.  Cryptosporidium pathogenicity and virulence.

Authors:  Maha Bouzid; Paul R Hunter; Rachel M Chalmers; Kevin M Tyler
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

6.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

7.  Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody.

Authors:  A M Cevallos; N Bhat; R Verdon; D H Hamer; B Stein; S Tzipori; M E Pereira; G T Keusch; H D Ward
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL.

Authors:  R C Langer; D A Schaefer; M W Riggs
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Biochemical and functional characterization of CpMuc4, a Cryptosporidium surface antigen that binds to host epithelial cells.

Authors:  John Paluszynski; Zachary Monahan; Maura Williams; Olivia Lai; Christopher Morris; Patrick Burns; Roberta O'Connor
Journal:  Mol Biochem Parasitol       Date:  2014-03-29       Impact factor: 1.759

10.  Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Cryptosporidium parvum infection in vitro.

Authors:  Roberta M O'Connor; Patrick B Burns; Tin Ha-Ngoc; Kristen Scarpato; Wasif Khan; Gagandeep Kang; Honorine Ward
Journal:  Eukaryot Cell       Date:  2009-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.